ArticleAmerican journal of physiology. Heart and circulatory physiology2025
Cholinergic suppression of heart rate acceleration during intrinsic optogenetic activation of sympathetic cardiac neurons in perfused hearts.
Article in American journal of physiology. Heart and circulatory physiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Chemogenetic activation of cholinergic intrinsic cardiac ganglia improves border zone oxygenation and reduces arrhythmias during acute local ischemia.Frontiers in cardiovascular medicine · 2026Article
- Optogenetic dissection of cardiac autonomic balance: illuminating the heart's dialogue between nerves and myocytes.American journal of physiology. Heart and circulatory physiology · 2026Article
Corrections and comments
- Commented on by
Authors and funding
7 authors.
Funding
Abstract
Cardiac autonomic pathways can be interrogated using optogenetics via selective expression of channelrhodopsin (ChR2) within intrinsic cardiac neurons. We tested the hypothesis that cholinergic activation via exogenous acetylcholine (ACh) would suppress the β-adrenergic heart rate (HR) acceleration induced by tyrosine hydroxylase (TH) neuron stimulation. HR responses were measured for wild-type (WT) mice at increasing norepinephrine (NE) concentrations and for transgenic mice that expressed ChR2 in TH neurons while illuminating the right atrium using a 465-nm microLED. Light pulse duty cycles (at 5 Hz) increasing from 5% to 50% caused proportional increases in HR; however, HR was unstable at duty cycles >30%. At 20% duty cycle, HR increased 39.43 ± 6.79%. HR increased for light pulse frequencies from 2.5 to 15 Hz (30 ms pulse width) but HR was unstable at 15 Hz. HR increases for photostimulated TH hearts and WT hearts perfused with NE (1-800 nM, WT + NE) had similar maxima but drastically different rise time constants (1.54 ± 0.08 vs. 18.04 ± 3.87 s, respectively). Increasing doses of ACh were added to the perfusate of WT + NE hearts and photostimulated TH hearts. High doses of ACh significantly diminished NE-induced and light-induced HR increases. Optogenetic activation of TH neurons caused rapid HR acceleration that was suppressed at higher ACh concentration than that required to suppress acceleration during NE perfusion. In WT + NE hearts, this occurred at 400 nM ACh and in TH hearts this did not occur until 1,800 nM ACh. Atrioventricular block occurred more rapidly in TH hearts during photostimulation as ACh concentration increased, demonstrating a time-dependent element in the interaction of simultaneous cholinergic and adrenergic activation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.